{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:38:46Z","timestamp":1791826726948,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.phrs.2022.106139","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T01:56:36Z","timestamp":1645408596000},"page":"106139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway"],"prefix":"10.1016","volume":"178","author":[{"given":"Gaozan","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongsuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunxuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanru","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhouxiang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitao","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Litai","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106139_bib1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41419-019-1994-2","article-title":"Progranulin attenuates liver fibrosis by downregulating the inflammatory response","volume":"10","author":"Yoo","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2022.106139_bib2","article-title":"Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues","volume":"105316","author":"Miao","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2022.106139_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2017.05.016","article-title":"Pathophysiology of liver fibrosis and the methodological barriers to the development of anti-fibrogenic agents","volume":"121","author":"Bottcher","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.phrs.2022.106139_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Ayd\u0131n","year":"2018","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2022.106139_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI93563","article-title":"Resolution of organ fibrosis","volume":"128","author":"Jun","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2022.106139_bib6","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1172\/JCI66369","article-title":"Hepatic stellate cells in liver development, regeneration, and cancer","volume":"123","author":"Yin","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2022.106139_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","article-title":"Senescence of activated stellate cells limits liver fibrosis","volume":"134","author":"Krizhanovsky","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2022.106139_bib8","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1053\/j.gastro.2012.07.115","article-title":"Hedgehog controls hepatic stellate cell fate by regulating metabolism","volume":"143","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2022.106139_bib9","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/ajpgi.00292.2009","article-title":"Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis","volume":"297","author":"Choi","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.phrs.2022.106139_bib10","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jhep.2007.07.032","article-title":"Sonic hedgehog is an autocrine viability factor for myofibroblastic hepatic stellate cells","volume":"48","author":"Yang","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2022.106139_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/cells8050468","article-title":"Role of the Hippo pathway in fibrosis and cancer","volume":"8","author":"Kim","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phrs.2022.106139_bib12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/hep.30990","article-title":"Yes-associated protein in kupffer cells enhances the production of proinflammatory cytokines and promotes the development of nonalcoholic steatohepatitis","volume":"72","author":"Song","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2022.106139_bib13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jhep.2015.04.011","article-title":"The Hippo pathway effector YAP controls mouse hepatic stellate cell activation","volume":"63","author":"Mannaerts","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2022.106139_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2018.12.003","article-title":"Liquiritigenin inhibits hepatic fibrogenesis and TGF-\u03b21\/Smad with Hippo\/YAP signal","volume":"62","author":"Lee","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2022.106139_bib15","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-020-14384-z","article-title":"Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase","volume":"11","author":"Byun","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2022.106139_bib16","article-title":"Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21\/FGFR1 signaling pathway","author":"Wu","year":"2021","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.phrs.2022.106139_bib17","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.devcel.2018.12.021","article-title":"FGF15 activates hippo signaling to suppress bile acid metabolism and liver tumorigenesis","volume":"48","author":"Ji","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.phrs.2022.106139_bib18","first-page":"567","article-title":"Fibroblast growth factor-21 ameliorates hepatic encephalopathy by activating the STAT3-SOCS3 pathway to inhibit activated hepatic stellate cells","volume":"19","author":"Opoku","year":"2020","journal-title":"EXCLI J."},{"key":"10.1016\/j.phrs.2022.106139_bib19","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41584-020-0469-2","article-title":"Fibroblast growth factor signalling in osteoarthritis and cartilage repair","volume":"16","author":"Xie","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"issue":"20","key":"10.1016\/j.phrs.2022.106139_bib20","article-title":"Circular RNA circPDE4D protects against osteoarthritis by binding to miR-103a-3p and regulating FGF18","volume":"S1525\u20130016","author":"Wu","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phrs.2022.106139_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.joca.2005.03.003","article-title":"Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis","volume":"13","author":"Moore","year":"2005","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.phrs.2022.106139_bib22","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.joca.2019.05.018","article-title":"Deleting suppressor of cytokine signaling-3 in chondrocytes reduces bone growth by disrupting mitogen-activated protein kinase signaling","volume":"27","author":"Liu","year":"2019","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.phrs.2022.106139_bib23","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.3389\/fonc.2020.01685","article-title":"FGF18 inhibits clear cell renal cell carcinoma proliferation and invasion via regulating epithelial-mesenchymal transition","volume":"10","author":"Yang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phrs.2022.106139_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.31247","article-title":"Hydrogen sulfide alleviates liver injury via S-sulfhydrated-Keap1\/Nrf2\/LRP1 pathway","volume":"73","author":"Zhao","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2022.106139_bib25","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1038\/s41467-020-19668-y","article-title":"AdipoR1\/AdipoR2 dual agonist recovers nonalcoholic steatohepatitis and related fibrosis via endoplasmic reticulum-mitochondria axis","volume":"11","author":"Xu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2022.106139_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/bph.13701","article-title":"Canonical hedgehog signalling regulates hepatic stellate cell-mediated angiogenesis in liver fibrosis","volume":"174","author":"Zhang","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106139_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nprot.2015.017","article-title":"High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers","volume":"10","author":"Mederacke","year":"2015","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.phrs.2022.106139_bib28","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.27332","article-title":"Hepatic inflammation and fibrosis: functional links and key pathways","volume":"61","author":"Seki","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2022.106139_bib29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biochi.2017.05.017","article-title":"Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo\/YAP and TGF-\u03b21\/Smad signaling","volume":"140","author":"Perumal","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.phrs.2022.106139_bib30","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.7150\/ijbs.28089","article-title":"Role of canonical Hedgehog signaling pathway in liver","volume":"14","author":"Gao","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2022.106139_bib31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.28542","article-title":"Hedgehog regulates yes-associated protein 1 in regenerating mouse liver","volume":"64","author":"Swiderska-Syn","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2022.106139_bib32","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2022.106139_bib33","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep.30810","article-title":"Direct and indirect effects of fibroblast growth factor (FGF) 15 and FGF19 on liver fibrosis development","volume":"71","author":"Schumacher","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2022.106139_bib34","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fcell.2020.00601","article-title":"Disruption of FGF signaling ameliorates inflammatory response in hepatic stellate cells","volume":"8","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.phrs.2022.106139_bib35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jconrel.2020.09.041","article-title":"Fibroblast growth factor 2 conjugated superparamagnetic iron oxide nanoparticles (FGF2-SPIONs) ameliorate hepatic stellate cells activation in vitro and acute liver injury in vivo","volume":"328","author":"Kurniawan","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.phrs.2022.106139_bib36","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1074\/jbc.M117.793794","article-title":"Fibroblast growth factor 2 (FGF2) regulates cytoglobin expression and activation of human hepatic stellate cells via JNK signaling","volume":"292","author":"Sato-Matsubara","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2022.106139_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2015.11.012","article-title":"Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-\u03b2\/smad2\/3 and NF-\u03baB signaling pathways","volume":"290","author":"Xu","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106139_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-pathol-030420-105050","article-title":"The Hippo pathway in liver homeostasis and pathophysiology","volume":"16","author":"Driskill","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.phrs.2022.106139_bib39","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","article-title":"The Hippo pathway: biology and pathophysiology","volume":"88","author":"Ma","year":"2019","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.phrs.2022.106139_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41580-018-0086-y","article-title":"Hippo-YAP\/TAZ signalling in organ regeneration and regenerative medicine","volume":"20","author":"Moya","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2022.106139_bib41","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ncb3111","article-title":"Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway","volume":"17","author":"Mo","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.phrs.2022.106139_bib42","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708699","article-title":"Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis","volume":"10","author":"Greenhough","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2022.106139_bib43","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1053\/j.gastro.2017.12.022","article-title":"Hedgehog-YAP signaling pathway regulates glutaminolysis to control activation of hepatic stellate cells","volume":"154","author":"Du","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2022.106139_bib44","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fphar.2017.00256","article-title":"SRT1720 alleviates ANIT-Induced cholestasis in a mouse model","volume":"8","author":"Yu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106139_bib45","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3389\/fphar.2017.00938","article-title":"Huangqi decoction alleviates alpha-naphthylisothiocyanate induced intrahepatic cholestasis by reversing disordered bile acid and glutathione homeostasis in mice","volume":"8","author":"Wu","year":"2017","journal-title":"Front. Pharmacol."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:30:28Z","timestamp":1760913028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":45,"alternative-id":["S1043661822000846"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106139","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106139"}}